Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1401-1410 of 1,467) with videos related to

Pageof 147
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid MalignanciesCourtney D DiNardo, Amir T Fathi, Ashwin Kishtagari, et al.
Annals of the Rheumatic Diseases|February 24, 2022
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 updateRobert B M Landewé, Féline P B Kroon, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaireBoulos Haraoui, Josef S Smolen, Daniel Aletaha, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaAngeliki Karatza, Maayan Pour, Jaylen M Powell, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|June 9, 2023
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritisAlen Zabotti, Gabriele De Marco, Laure Gossec, et al.
Annals of the Rheumatic Diseases|April 13, 2018
Treating juvenile idiopathic arthritis to target: recommendations of an international task forceAngelo Ravelli, Alessandro Consolaro, Gerd Horneff, et al.
Annals of the Rheumatic Diseases|March 6, 2012
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisDanielle M Gerlag, Karim Raza, Lisa G M van Baarsen, et al.
Annals of the Rheumatic Diseases|December 9, 2015
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 updateL Gossec, J S Smolen, S Ramiro, et al.
Pageof 147

Showing results (1401-1410 of 1,467) with videos related to

Sort By:
Pageof 147
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid MalignanciesCourtney D DiNardo, Amir T Fathi, Ashwin Kishtagari, et al.
Annals of the Rheumatic Diseases|February 24, 2022
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 updateRobert B M Landewé, Féline P B Kroon, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaireBoulos Haraoui, Josef S Smolen, Daniel Aletaha, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Cross-species analysis identifies genotype-driven vulnerabilities in lung adenocarcinomaAngeliki Karatza, Maayan Pour, Jaylen M Powell, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementPeter Nash, Andreas Kerschbaumer, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|June 11, 2013
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceJosef S Smolen, Jürgen Braun, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|June 9, 2023
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritisAlen Zabotti, Gabriele De Marco, Laure Gossec, et al.
Annals of the Rheumatic Diseases|April 13, 2018
Treating juvenile idiopathic arthritis to target: recommendations of an international task forceAngelo Ravelli, Alessandro Consolaro, Gerd Horneff, et al.
Annals of the Rheumatic Diseases|March 6, 2012
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisDanielle M Gerlag, Karim Raza, Lisa G M van Baarsen, et al.
Annals of the Rheumatic Diseases|December 9, 2015
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 updateL Gossec, J S Smolen, S Ramiro, et al.
Pageof 147